In 2002 was created Sinowisdom, which is appeared as VC. The main office of represented VC is situated in the Hangzhou. The company was established in Asia in China.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Software, Health Care. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline PingPong, ChineseAll Digital Publishing, Deepdraw Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Comparing to the other companies, this Sinowisdom performs on 17 percentage points less the average number of lead investments. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 4 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Sinowisdom, startups are often financed by Northern Light Venture Capital, Eight Roads Ventures, CICC. The meaningful sponsors for the fund in investment in the same round are CrestValue, ZSVC, Yizheng Tiandao. In the next rounds fund is usually obtained by Zero2IPO Ventures, Yizheng Tiandao, Yinxinggu Capital.
This organization was formed by Peimin Zong.
Related Funds
Funds with similar focus
Fund Name | Location |
Benori Ventures | Gurgaon, Haryana, India |
Binary Financial | Blaine, United States, Washington |
City Capital Ventures | Chicago, Illinois, United States |
Cybele Holdings | Israel, Ramat Gan, Tel Aviv |
Fuchengwan Touzi | China, Guangdong, Tianjin |
Hanwha Holdings | Seoul, Seoul-t'ukpyolsi, South Korea |
Haofubao | China, Haikou, Hainan |
Leichen Touzi | China, Guangdong, Guangzhou |
Phoenix Mills | India, Maharashtra, Mumbai |
Qualcomm Robotics Accelerator | California, San Diego, United States |
RUSNANO | California, Menlo Park, United States |
Shanghai Morning Post | China, Shanghai |
Shienbi Investment | Beijing, Beijing, China |
sweemie | Japan, Osaka, Osaka Prefecture |
Third Act Ventures | New York, New York, United States |
Trently Advisors | California, Kentucky, United States |
Union Bay Partners | Seattle, United States, Washington |
Win Fund | Canada, Ontario, Ottawa |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Fansheng Intelligent Control | 01 Mar 2024 | Huzhou, Zhejiang, China | |||
Barty Medical | $15M | 14 Dec 2023 | Shangcheng District, Zhejiang, China | ||
Biosun Pharma | 12 Oct 2023 | Hangzhou, Zhejiang, China | |||
CLiS | 29 Apr 2023 | Taizhou, Jiangsu, China | |||
Yanhuang Guoxin | 28 Apr 2023 | Changping, Beijing, China | |||
DEEPerceptron | 24 Apr 2023 | Yinzhou District, Zhejiang, China | |||
Yaoyu Technology | 29 Jan 2023 | Shenzhen, Guangdong, China | |||
Zhide New Energy | 01 Jan 2023 | Jinhua, Zhejiang, China | |||
Yugu Technology | 06 Apr 2022 | Hangzhou, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Fansheng Intelligent Control | 01 Mar 2024 | Huzhou, Zhejiang, China | |||
Barty Medical | $15M | 14 Dec 2023 | Shangcheng District, Zhejiang, China | ||
Biosun Pharma | 12 Oct 2023 | Hangzhou, Zhejiang, China | |||
CLiS | 29 Apr 2023 | Taizhou, Jiangsu, China | |||
Yanhuang Guoxin | 28 Apr 2023 | Changping, Beijing, China | |||
DEEPerceptron | 24 Apr 2023 | Yinzhou District, Zhejiang, China | |||
Yaoyu Technology | 29 Jan 2023 | Shenzhen, Guangdong, China | |||
Zhide New Energy | 01 Jan 2023 | Jinhua, Zhejiang, China | |||
Yugu Technology | 06 Apr 2022 | Hangzhou, Zhejiang, China |